Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$15.39 - $20.25 $255,212 - $335,805
-16,583 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$15.91 - $18.72 $97,241 - $114,416
-6,112 Reduced 26.93%
16,583 $286,000
Q3 2021

Nov 15, 2021

BUY
$13.06 - $17.24 $296,396 - $391,261
22,695 New
22,695 $379,000
Q3 2020

Nov 16, 2020

SELL
$10.33 - $14.49 $156,726 - $219,842
-15,172 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$11.49 - $15.26 $25,461 - $33,816
2,216 Added 17.1%
15,172 $212,000
Q1 2020

May 15, 2020

SELL
$8.11 - $15.23 $6,593 - $12,381
-813 Reduced 5.9%
12,956 $152,000
Q4 2019

Feb 14, 2020

SELL
$10.28 - $14.38 $667,624 - $933,894
-64,944 Reduced 82.51%
13,769 $195,000
Q3 2019

Nov 14, 2019

SELL
$10.05 - $14.55 $32,682 - $47,316
-3,252 Reduced 3.97%
78,713 $830,000
Q2 2019

Aug 14, 2019

BUY
$13.1 - $14.95 $259,733 - $296,413
19,827 Added 31.91%
81,965 $1.19 Million
Q1 2019

May 15, 2019

BUY
$13.69 - $20.06 $48,969 - $71,754
3,577 Added 6.11%
62,138 $872,000
Q4 2018

Feb 14, 2019

SELL
$13.96 - $18.26 $239,595 - $313,396
-17,163 Reduced 22.67%
58,561 $1.02 Million
Q3 2018

Nov 14, 2018

SELL
$13.63 - $15.7 $83,320 - $95,974
-6,113 Reduced 7.47%
75,724 $1.15 Million
Q2 2018

Aug 14, 2018

SELL
$13.44 - $17.59 $175,486 - $229,672
-13,057 Reduced 13.76%
81,837 $1.13 Million
Q1 2018

May 15, 2018

BUY
$13.8 - $16.99 $187,114 - $230,367
13,559 Added 16.67%
94,894 $1.58 Million
Q4 2017

Feb 14, 2018

SELL
$11.73 - $14.75 $97,687 - $122,838
-8,328 Reduced 9.29%
81,335 $1.15 Million
Q3 2017

Nov 14, 2017

BUY
$12.06 - $14.12 $1.08 Million - $1.27 Million
89,663
89,663 $1.27 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.